TY - JOUR AU - Wang, Xiao Jun AU - Saha, Ashwini AU - Zhang, Xu-Hao PY - 2017 DA - 2017/08/22 TI - Cost-effectiveness analysis of a universal mass vaccination program with a PHiD-CV 2+1 schedule in Malaysia JO - Cost Effectiveness and Resource Allocation SP - 17 VL - 15 IS - 1 AB - Currently, two pediatric pneumococcal conjugate vaccines are available in the private market of Malaysia—13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide and non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). This study aimed to evaluate the cost-effectiveness of a universal mass vaccination program with a PHiD-CV 2+1 schedule versus no vaccination or with a PCV13 2+1 schedule in Malaysia. SN - 1478-7547 UR - https://doi.org/10.1186/s12962-017-0079-2 DO - 10.1186/s12962-017-0079-2 ID - Wang2017 ER -